MYX enters Scheme Implementation Deed with Gedeon Richter
Filed with ASX · · 112 pages · English
Summary by 6ix AI
Mayne Pharma Group Ltd. has announced that it has entered into a Scheme Implementation Deed with Gedeon Richter for the acquisition of Mayne Pharma shares at a specified cash price per share, valuing the company significantly higher than its recent trading price. The transaction is subject to customary conditions, including regulatory approvals and shareholder consent, with an indicative timeline for implementation provided.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- AGM updates
- Investor presentation re International segment divestment
- Mayne Pharma to divest International segment for $55.5m
- Notification regarding unquoted securities - MYX
- Investor presentation
Later from Mayne Pharma
- Investor presentation re Scheme with Gedeon Richter
- AGM update - withdrawal of Brett Wells director resolution
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma